. @AnteoTech_ (#ASX: $ADO) has been highlighted in a new MST Access research report with a valuation of $0.097 per share, compared to a share price of $0.035, implying potential upside of approximately 177%.
The report points to growing momentum across both the battery and life sciences divisions, including validation of Ultranode 95 in a commercial format drone battery cell and discussions with two US drone battery manufacturers regarding potential joint development agreements.
MST said AnteoTech has "achieved another important step towards commercial deployment of its drone battery components", while also highlighting new agreements in South Korea and Japan and up to $10 million raised through the recent option exercise process.
The report notes that new management has accelerated the sales pipeline, closed deals and advanced strategic relationships across both the Advanced Battery Technology and Life Sciences divisions.
#ADO #AnteoTech #BatteryTechnology #LifeSciences #DroneBatteries #SiliconAnodes #ASX
. @AnteoTech_ (#ASX: $ADO) has been featured in Far East Capital’s latest Weekly Commentary, with analyst Warwick Grigor saying the company is “getting its mojo back” as the market begins to recognise the progress being made across its battery technology platform.
The report highlights the recent third party validation of Ultranode™ 95 by the Battery Innovation Centre in the US, with Grigor noting the technology is “commercially scaleable” and highlighting its potential across drone and defence applications.
Far East Capital also pointed to AnteoTech’s new collaboration with Xerabrid Corporation in battery separators and the appointment of Cosmo Bio Co Ltd as a distributor for its Life Sciences products in Japan, describing the recent announcements as helping steer the company “back into the fast lane of the market.”
Read the full $ADO Commentary here: https://t.co/Y8cESVCvTR
#BatteryTechnology #Ultranode95 #DefenceTech #Drones #LifeSciences #Innovation #EnergyStorage
Tylah Tully sits down with @AnteoTech_ managing director Merrill Gray to discuss recent US validation results for the company’s Ultranode 95 silicon anode technology and how it could enhance next-generation drone batteries. https://t.co/Z0G6LUKGOr #ASX $ADO
We’ve expanded in Japan with the appointment of Tokyo Stock Exchange listed life sciences distributor Cosmo Bio to supply AnteoBind™ and related products in Japan, effective immediately.
Cosmo Bio works with more than 600 suppliers and has a well-established domestic distribution model servicing universities, public research institutes, and life sciences companies throughout Japan.
We’re progressing work on the diversification of our product portfolio to include ELISA and CLIA products utilising AnteoBind NXT™ to activate surfaces and particles and deliver high-performing, lower-cost products into the market.
This appointment supports the commercial expansion strategy of AnteoTech’s Life Sciences business and establishes a non-exclusive sales channel for AnteoBind™ products in Japan.
Read the full $ADO ASX Announcement here: https://t.co/Uf84dXpRDr
#LifeSciences #Diagnostics #IVD #Immunoassays #ELISA #CLIA #Biotechnology #Japan
Our CEO & Managing Director Merrill Gray recently joined Tim Boreham on the Stock Insiders Podcast to discuss AnteoTech’s push into next-generation battery materials and advanced life sciences diagnostics.
The discussion covers Ultranode™ 95, the growing military drone market opportunity, recent third-party battery validation work in the US, and the commercial opportunities emerging from demand for higher-performance batteries and secure supply chains.
Merrill also discusses AnteoTech’s Life Sciences business, including AnteoBind™ and expansion into new testing markets through partnerships and commercial collaborations across India and Asia.
Listen to the full $ADO podcast below.
Listen here: https://t.co/7Xs7oQPvFC
#ADO #AnteoTech #BatteryTechnology #LifeSciences #Ultranode95 #Diagnostics #DroneTechnology #LithiumIonBatteries #EnergyStorage #ASX
We’ve signed a Strategic Collaboration and Sales Agreement Term Sheet with South Korean high performance separator technology company Xerabrid.
The Agreement combines Anteo S™, our proprietary cross-linking separator product, with Xerabrid’s ceramic coated separator technology know-how across next generation battery separators designed to reduce the risk of thermal runaway that leads to battery fires in batteries and improving battery safety.
Anteo S™ can be used across a wide range of battery anode chemistries including high silicon, graphite, silicon composite, lithium sulphur, lithium metal and sodium-ion. Demand for improved separator performance has seen rapid acceleration of Anteo S™ sample requests received from separator manufacturers globally.
Read the full $ADO #ASX Announcement here: https://t.co/eDe092sY6g
#BatteryTechnology #BatterySafety #LithiumIonBatteries #EnergyStorage #EV #BESS
AnteoTech Validates Ultranode 95 in Commercial Cell Format for Drone and UAV Markets | $ADO Media coverage by @SmallCapsASX.
https://t.co/Jcc6HKaXxZ
#ADO#AnteoTech#BatteryTechnology
$ADO AnteocTech shares have soared following positive results from testing for its trademarked Ultranode95, with an independent assessment in the US indicating its suitability for drone and UAV applications.
@AnteoTech_
https://t.co/2HyaYssEib
We’ve been highlighted as a “What’s Hot” stock in Rat’s Rant following the independent third-party validation of our Ultranode™ 95 in commercial-format Multi-Layer Pouch cells at the Battery Innovation Centre in the US.
The report highlighted Ultranode™ 95’s >390 Wh/kg potential, strong cycle life performance and ongoing engagement with prospective drone battery customers.
More here: https://t.co/lLIRP6OCw5
$ADO #AnteoTech #Ultranode95 #BatteryTechnology #DroneTechnology #UAV #LithiumIonBatteries #EnergyStorage
Special Report: AnteoTech has taken a leap down the path to commercialisation for its Ultranode™ 95 technology, completing independent third-party validation of its 5Ah multi-layer pouch battery cells.
Independent validation completed in 5Ah multi-layer pouch cells
Energy density greater than 390Wh/kg at battery cell level potential, 40% higher than traditional anodes
Characteristics highly suited for drones, UAVs, robotics, medical devices and consumer devices
$ADO Media coverage by @australian
https://t.co/NtyJoS0Q4k
Independent third-party validation of Ultranode™ 95 in a commercial-format Multi-Layer Pouch cell has been completed at the Battery Innovation Centre (BIC) in the United States.
The results demonstrate what Ultranode™ 95 can deliver in a commercial battery format:
• >390 Wh/kg specific energy density — more than 40% higher than traditional anodes
• 300+ cycles at 70% capacity retention, exceeding target performance levels for many defence drone applications
• Bottom quartile cost base using readily available micro-silicon from a secure global supply chain.
This performance profile is well suited to drones, UAVs, robotics, medical devices and consumer electronics. Multiple potential customers have received Ultranode™ 95 for internal evaluation, with positive feedback to date.
The next step is fabrication and testing of 18650 cylindrical cells incorporating Ultranode™ 95 at BIC, with production already underway.
🔗 Read the full announcement: https://t.co/qD8iqzdtpR
$ADO #AnteoTech #Ultranode #BatteryTechnology #Drones #UAV #ASX #InvestorUpdate
We’re looking forward to attending the Gold Coast Investment Showcase on 11 & 12 June 2026 at the JW Marriott Gold Coast Resort & Spa, QLD.
Managing Director & CEO Merrill Gray will present on Thursday, 11 June, at 2:15 pm, providing an update on AnteoTech’s Advanced Battery Technologies and Life Sciences businesses, including recent progress across Ultranode™ 95, Anteo S™, SiMRAX and AnteoBind™ NXT.
To register: https://t.co/Ij0jUu0fpU
$ADO #AnteoTech #ASX #BatteryTechnology #LifeSciences #CriticalMinerals #SiliconAnodes #Diagnostics #Investing @VEvents_RIU
Our Quarterly Activities Report for the period ending 31 March 2026 has been released.
View the full $ADO report: https://t.co/UTwsLXWh24
#BatteryTechnology#LifeSciences#ASXNews
Last week, our CEO & Managing Director Merrill Gray presented at the @NWRcomms Virtual Healthcare Conference, sharing how AnteoBind™ is enabling the next generation of biosensor diagnostics.
Biosensors are transforming the way we detect disease. Worn on the body, these devices can capture biomarkers in real time, with early research demonstrating the potential to detect the earliest traces of a cardiac event as it's happening.
AnteoBind™ plays a critical role in activating the sensors that make this level of sensitivity possible, enabling precise, real-time signal detection through superior antibody orientation and surface chemistry performance.
Watch the full replay here: https://t.co/egaP3l8GGa
$ADO #Anteotech #HealthcareConference #Biotech #InvestorUpdate #Webinar #ASX